Innate Pharma SA operates in Healthcare, within the Biological Products, (No Diagnostic Substances) industry.
Innate Pharma SA key market context on AlphaOS includes Sector: Healthcare; Industry: Biological Products, (No Diagnostic Substances); Market capitalization: $169.63M; Recent price: $1.81. Figures update as market data and SEC filings are ingested.
Peers and competitive context often cited for Innate Pharma SA include LLY, BDRX, JNJ, ABBV, MRK, ABT. Explore industry and sector pages on AlphaOS for thematic exposure and supply-chain links.
Use this IPHA research hub for earnings transcripts, SEC filings, opportunity scoring, news, and knowledge-graph relationships. Content is for research and education only — not investment advice.